Trial · NCT00295620
Adverse events1,550
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 1,550
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| serious | Anaemia | Blood and lymphatic system disorders | Arm B: Anastrozol - 1 mg Per Day for 5 Years | 1 | 1,710 | 2 |
| serious | Anaemia | Blood and lymphatic system disorders | Arm A: Anastrozol - 1 mg Per Day for 2 Years | 1 | 1,705 | 2 |
| serious | Anaemia macrocytic | Blood and lymphatic system disorders | Arm B: Anastrozol - 1 mg Per Day for 5 Years | 0 | 1,710 | 0 |
| serious | Anaemia macrocytic | Blood and lymphatic system disorders | Arm A: Anastrozol - 1 mg Per Day for 2 Years | 1 | 1,705 | 2 |
| serious | Bone marrow oedema | Blood and lymphatic system disorders | Arm B: Anastrozol - 1 mg Per Day for 5 Years | 3 | 1,710 | 3 |
| serious | Bone marrow oedema | Blood and lymphatic system disorders | Arm A: Anastrozol - 1 mg Per Day for 2 Years | 0 | 1,705 | 0 |
| serious | Haemolytic anaemia | Blood and lymphatic system disorders | Arm B: Anastrozol - 1 mg Per Day for 5 Years | 1 | 1,710 | 1 |
| serious | Haemolytic anaemia | Blood and lymphatic system disorders | Arm A: Anastrozol - 1 mg Per Day for 2 Years | 0 | 1,705 | 0 |
| serious | Immune thrombocytopenic purpura | Blood and lymphatic system disorders | Arm B: Anastrozol - 1 mg Per Day for 5 Years | 1 | 1,710 | 2 |
| serious | Immune thrombocytopenic purpura | Blood and lymphatic system disorders | Arm A: Anastrozol - 1 mg Per Day for 2 Years | 0 | 1,705 | 0 |
| serious | Leukopenia | Blood and lymphatic system disorders | Arm B: Anastrozol - 1 mg Per Day for 5 Years | 0 | 1,710 | 0 |
| serious | Leukopenia | Blood and lymphatic system disorders | Arm A: Anastrozol - 1 mg Per Day for 2 Years | 1 | 1,705 | 2 |
| serious | Lymph node calcification | Blood and lymphatic system disorders | Arm B: Anastrozol - 1 mg Per Day for 5 Years | 1 | 1,710 | 1 |
| serious | Lymph node calcification | Blood and lymphatic system disorders | Arm A: Anastrozol - 1 mg Per Day for 2 Years | 0 | 1,705 | 0 |
| serious | Lymphadenitis | Blood and lymphatic system disorders | Arm B: Anastrozol - 1 mg Per Day for 5 Years | 1 | 1,710 | 1 |
| serious | Lymphadenitis | Blood and lymphatic system disorders | Arm A: Anastrozol - 1 mg Per Day for 2 Years | 0 | 1,705 | 0 |
| serious | Lymphadenopathy | Blood and lymphatic system disorders | Arm B: Anastrozol - 1 mg Per Day for 5 Years | 3 | 1,710 | 6 |
| serious | Lymphadenopathy | Blood and lymphatic system disorders | Arm A: Anastrozol - 1 mg Per Day for 2 Years | 0 | 1,705 | 0 |
| serious | Mastocytosis | Blood and lymphatic system disorders | Arm B: Anastrozol - 1 mg Per Day for 5 Years | 1 | 1,710 | 2 |
| serious | Mastocytosis | Blood and lymphatic system disorders | Arm A: Anastrozol - 1 mg Per Day for 2 Years | 0 | 1,705 | 0 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00295620/events